Audible Premium Plus. $0.99/mo for the first 3 months + $20 Audible credits. 12 days only. Get this deal. Cancel anytime.

Dr. Oz’s CMS Nomination, UnitedHealth Antitrust Challenges, and Medicare Advantage Insights with Jakob Emerson
Nov 21 2024
Length: 15 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Dr. Oz’s CMS Nomination, UnitedHealth Antitrust Challenges, and Medicare Advantage Insights with Jakob Emerson

Listen for free

View show details

Summary
In this episode, Jakob Emerson, Associate News Director at Becker’s Healthcare, explores the implications of Dr. Mehmet Oz’s nomination to lead CMS, UnitedHealth Group’s ongoing antitrust battles, and the evolving role of Medicare Advantage in the payer landscape. Tune in for expert analysis on these pivotal healthcare developments.

Show more Show less

Show more Show less

What listeners say about Dr. Oz’s CMS Nomination, UnitedHealth Antitrust Challenges, and Medicare Advantage Insights with Jakob Emerson

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon